arsenic has been researched along with Cholangiocellular Carcinoma in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 4 (80.00) | 24.3611 |
| 2020's | 1 (20.00) | 2.80 |
| Authors | Studies |
|---|---|
| Baek, SY; Kim, EY; Kim, SH; Lee, SS; Shin, DH; Shin, JH | 1 |
| Dai, H; Ling, S; Shan, Q; Song, P; Wei, X; Xie, H; Xu, X; Yang, F; Zheng, S; Zhou, L; Zhuo, J | 1 |
| Lv, XH; Wang, CH; Xie, Y | 1 |
| Shao, C; Wu, X; Yang, J; Zhang, S; Zhong, F | 1 |
| Boffetta, P; Ganesan, N; Labgaa, I; Reyes, D | 1 |
1 review(s) available for arsenic and Cholangiocellular Carcinoma
| Article | Year |
|---|---|
Arsenic trioxide combined with transarterial chemoembolization for primary liver cancer: A meta-analysis.
Topics: Adult; Aged; Aged, 80 and over; Arsenic Trioxide; Arsenicals; Carcinoma, Hepatocellular; Chemoembolization, Therapeutic; Chemotherapy, Adjuvant; Cholangiocarcinoma; Databases, Bibliographic; Female; Humans; Infusions, Intra-Arterial; Infusions, Intravenous; Liver Neoplasms; Male; Middle Aged; Oxides; Randomized Controlled Trials as Topic; Treatment Outcome; Young Adult | 2017 |
4 other study(ies) available for arsenic and Cholangiocellular Carcinoma
| Article | Year |
|---|---|
Anticancer effect of arsenic trioxide on cholangiocarcinoma: in vitro experiments and in vivo xenograft mouse model.
Topics: Animals; Antineoplastic Agents; Arsenic Trioxide; Arsenicals; Cell Line, Tumor; Cell Proliferation; Cell Survival; Cholangiocarcinoma; Disease Models, Animal; Heterografts; Humans; Mice, Inbred BALB C; Mice, Nude; Oxides; Staining and Labeling; Tetrazolium Salts; Thiazoles; Treatment Outcome | 2014 |
Metformin potentiates the effect of arsenic trioxide suppressing intrahepatic cholangiocarcinoma: roles of p38 MAPK, ERK3, and mTORC1.
Topics: AMP-Activated Protein Kinases; Animals; Arsenic Trioxide; Arsenicals; Bile Duct Neoplasms; Cell Line, Tumor; Cholangiocarcinoma; Drug Synergism; Heterografts; Humans; Mechanistic Target of Rapamycin Complex 1; Metformin; Mice; Mice, Nude; Mitogen-Activated Protein Kinase 6; Oxides; p38 Mitogen-Activated Protein Kinases; Signal Transduction | 2017 |
Arsenic trioxide inhibits cholangiocarcinoma cell growth and induces apoptosis.
Topics: Apoptosis; Arsenic Trioxide; Arsenicals; Bile Duct Neoplasms; Bile Ducts, Intrahepatic; Blotting, Western; Cell Line, Tumor; Cell Proliferation; Cell Separation; Cholangiocarcinoma; Flow Cytometry; Humans; Oxides; Signal Transduction | 2010 |
Arsenic-contaminated drinking water and cholangiocarcinoma.
Topics: Arsenic; Bile Duct Neoplasms; Bile Ducts, Extrahepatic; Bile Ducts, Intrahepatic; Cholangiocarcinoma; Drinking Water; Female; Humans; Male | 2023 |